NCT03055013 2026-03-17Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing NephrectomyNational Cancer Institute (NCI)Phase 3 Active not recruiting819 enrolled 12 charts
NCT04370509 2025-11-19Pembrolizumab With or Without Axitinib for Clear Cell Kidney Cancer in Patients Undergoing SurgeryUniversity of California, San FranciscoPhase 2 Terminated6 enrolled 11 charts